ArticleAnnals of the rheumatic diseases2021

Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting.

Yusuke Miyazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.